Takeda Pharmaceutical Company Ltd
๐ฏ๐ตJapan
- Country
- ๐ฏ๐ตJapan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
Phase 3
Completed
- Conditions
- Pneumonia
- First Posted Date
- 2003-12-25
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1200
- Registration Number
- NCT00074906
- Locations
- ๐ฌ๐ง
Altana Pharma/Nycomed, West Lothian, United Kingdom
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
- First Posted Date
- 2002-11-21
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 204
- Registration Number
- NCT00050076
- Locations
- ๐บ๐ธ
LAC & USC Medical Center, Los Angeles, California, United States
๐บ๐ธApex Research Institute, Santa Ana, California, United States
๐บ๐ธMedical Group of Fort Wayne, PC, Fort Wayne, Indiana, United States
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2
Phase 1
Completed
- Conditions
- Breast NeoplasmPancreatic NeoplasmLung NeoplasmOvarian NeoplasmRenal Neoplasm
- Interventions
- Drug: TAK-165
- First Posted Date
- 2002-04-25
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 16
- Registration Number
- NCT00034281
- Locations
- ๐บ๐ธ
The Institute for Drug Development, San Antonio, Texas, United States
๐บ๐ธSouth Texas VA, Audie Murphy Division, San Antonio, Texas, United States
๐บ๐ธArizona Cancer Center, Scottsdale, Arizona, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath